Pretty v United Kingdom

Pretty v United Kingdom
Case name	Pretty v United Kingdom
Court	European Court of Human Rights
Decision date	29 April 2002
Citation	Application No. 2346/02
Judges	Bowie, Costa, Bratza, Pal/?s?, Rozakis, Wildhaber, Hajiyev, Rozakis, Jungwiert

Pretty v United Kingdom Diane Pretty's case tested the intersection of assisted dying, criminal law and human rights before the European Court of Human Rights. The decision engaged instruments and institutions across United Kingdom criminal procedure, European Convention on Human Rights, and transnational debates involving World Medical Association, British Medical Association, and disability rights organizations. The ruling influenced discussions in jurisdictions such as Canada, Netherlands, Switzerland, Belgium, and Australia.

Background

Diane Pretty, a national of the United Kingdom, suffered from motor neurone disease and sought a legal exemption from prosecution under the Offences Against the Person Act 1861 and the Suicide Act 1961 to permit her husband to assist her death. Pretty invoked rights under the European Convention on Human Rights including Articles 2, 3, 8, 9 and 14 and relied on principles articulated in earlier Strasbourg jurisprudence such as Dudgeon v. United Kingdom, McCann v United Kingdom, Pretty v United Kingdom (application stage referenced in domestic litigation), and comparative rulings including Lambert and Others v. France and Haas v. Switzerland. Domestic interlocutory proceedings involved the House of Lords and the Court of Appeal as part of a broader litany of challenges to the Director of Public Prosecutions's prosecutorial discretion.

Facts of the Case

Diane Pretty, diagnosed with motor neurone disease, sought a declaration that her husband, should he assist her suicide, would not be prosecuted under the Suicide Act 1961 or for homicide under the Offences Against the Person Act 1861. She applied to the European Court of Human Rights after domestic remedies in the United Kingdom courts, including appeals touching on the Human Rights Act 1998, failed to secure immunity. The applicant argued that prosecuting her husband would violate her autonomy as protected by Article 8 of the European Convention on Human Rights and that a denial of an assisted death amounted to degrading treatment under Article 3, invoking comparative practice in Netherlands law and policy debates involving the Royal College of Physicians and advocacy groups such as Dignitas and Human Rights Watch.

Legal Issues Presented

The case presented whether Article 2 (right to life) could be interpreted to include a right to die, whether Article 3 (prohibition of torture and inhuman or degrading treatment) encompassed a duty to permit assistance in dying, and whether Article 8 (right to respect for private and family life) conferred a right to assisted suicide or a positive obligation on States to safeguard assisted dying under regulated conditions. Additional questions addressed whether a prohibition on assisted suicide could be compatible with Article 14 (prohibition of discrimination) when combined with other Convention rights, and how the State's margin of appreciation doctrine applied in bioethical matters involving the European Court of Human Rights, jurisprudence from Pretty v United Kingdom context, and precedent from Soering v. United Kingdom and Pretty v United Kingdom-related submissions.

Judgment and Reasoning

The European Court of Human Rights held that Article 2 could not be interpreted as conferring a right to die and that Article 3 was not violated by the prohibition on assisted suicide given the margin of appreciation afforded to Contracting States. The Court recognized that Article 8 was engaged because the case raised questions about private life and personal autonomy, but concluded that the interference with Article 8 rights was justified and proportionate in pursuit of the legitimate aims of protecting vulnerable persons and the rights of others. The Court applied reasoning influenced by precedents such as Pretty v United Kingdom filings referencing Handyside v. United Kingdom and balancing tests like those in Golder v. United Kingdom and Klass and Others v. Germany, emphasizing the State's margin of appreciation and the lack of consensus among Council of Europe member States on assisted dying. The judgment rejected Article 14 discrimination claims in light of differential treatment justified by protection of vulnerable groups and public safety.

Impact and Significance

The decision clarified that the European Convention on Human Rights does not impose on Contracting States a positive obligation to permit assisted suicide, shaping legislative and judicial approaches in United Kingdom institutions including subsequent debates in the House of Commons, House of Lords, and guidance from the Director of Public Prosecutions. The ruling influenced comparative constitutional litigation in Canada (notably in proceedings preceding later cases), informed regulatory debates in Switzerland and Netherlands, and became a focal point for advocacy by organizations such as Dignity in Dying, Liberty (UK), and Amnesty International. Medical bodies including the British Medical Association and legal scholars cited the case in policy papers and academic commentary following decisions like R (Nicklinson) v. Ministry of Justice and Conway v. Rimmer-style inquiries.

Subsequent Developments and Related Jurisprudence

Post-2002 litigation revisited assisted dying in Strasbourg and domestic courts, including cases such as Pretty v United Kingdom-influenced appeals, R (Nicklinson) v. Ministry of Justice, and later Constitutional Court or high court decisions in Canada (Carter v Canada (Attorney General) context), Belgium and Switzerland. The European Court of Human Rights continued to address end-of-life questions in cases like Lambert and Others v. France, Gross v. Switzerland, and Haas v. Switzerland, refining standards on Article 8 positive obligations, the margin of appreciation, and the role of medical ethics bodies including the European Court of Human Rights's engagement with World Medical Association guidance. Scholarly commentary in journals associated with University of Oxford, University of Cambridge, Harvard Law School, and think tanks such as the Institute of Public Affairs and Chatham House debated the decision's implications for human rights, bioethics, and legislative reform.

Category:European Court of Human Rights cases